Available in Europe since 2020, this new system delivers the strongest clinical outcomes and best user experience to-date within the Medtronic family of pumps "Mealtimes prove to be one of the biggest ...

Late last week, medical device giant Medtronic received FDA approval for its MiniMed 780G system. The device is an insulin pump that automatically adjusts and corrects type 1 diabetes patients’ ...

Medtronic plc’s MDT most advanced automated insulin delivery (AID) system, MiniMed 780G, was recently recognized by the Fast Company in the Best World-Changing Idea, North America category as part of ...

After a long delay, the U.S. Food and Drug Administration has approved Medtronic's MiniMed 780G device, the company's next-generation insulin pump. Medtronic's diabetes division has been under a ...

It’s traditionally been particularly difficult to manage diabetes in highly active, still-developing children, but increasingly advanced glucose monitors and insulin delivery systems are aiming to ...

Medtronic has collected a European approval that allows it to combine its latest automated insulin pump with its newest glucose sensor for the first time. The CE mark covers the MiniMed 780G pump and ...

Medtronic plc MDT recently announced two regulatory milestones for its MiniMed 780G system portfolio. The FDA has cleared the company’s SmartGuard algorithm as an interoperable automated glycemic ...

The MiniMed 780G system has been approved for children aged 7 years and up with type 1 diabetes (T1D), according to Medtronic. The FDA has approved Medtronic’s MiniMed 780G system with Guardian 4 ...

Medtronic has announced that its long-awaited 780G diabetic therapy system has gained FDA approval which includes support for iPhone and Apple Watch monitoring. The Medtronic 780G system encompasses ...

Wide-moat Medtronic received highly welcome news today as the U.S. Food and Drug Administration has (finally) approved the firm’s next-gen 780g insulin pump, and we’re leaving our $112 fair value ...